Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
2023 · Nature Medicine · 245 citations
https://doi.org/10.1038/s41591-023-02347-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
580
Citations
11
h-index
11
i10-index
Maxim Yankelevich is an academic researcher from University of Michigan. The author has contributed to research in topics: Neutropenia and Cancer Infections & Glioma Diagnosis and Treatment & Hematopoietic Stem Cell Transplantation. The author has an h-index of 11, co-authored 31 publications.
ORCID: 0000-0002-1403-1399https://doi.org/10.1038/s41591-023-02347-y
https://doi.org/10.1002/pbc.24237
Click to start Chat